Lipid, lipoprotein, isotopic profile and atherogenic risk in sickle cell disease in Côte d'Ivoire;Profil lipidoprotéinique, isotopique et risque athérogène dans la drépanocytose en Côte d'Ivoire

Medecine Nucleaire

Volumn 34, Issue SUPPL. 1, 2010, Pages

  Monde A A ^a   Kouame Koutouan A ^a   Tiahou, G G ^b   Camara, C M ^a   Yapo, A A ^a   Djessou, S P ^a   Sess, E D ^a  

^a UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^b Université de Bouaké   (Côte d’Ivoire)

Author keywords

Atherogenic risk; Electrophoresis; Lipids; Lipoproteins profile; Sickle cell disease

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COTE D'IVOIRE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SICKLE CELL ANEMIA;

EID: 77957948978     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mednuc.2010.07.015     Document Type: Article

References (19)

1. Shores J., Peterson J., VanderJagt D., Glew R.H. Reduced cholesterol levels in African-American adults with sickle cell disease. J Natl Med Assoc 2003, 95:813-817.
2. Sess E.D., Carbonneau M.A., Thomas M.J. Premières observations sur les principaux paramètres plasmatiques de stress Oxydant chez le drépanocytaire homozygote. Bull Soc Path Ex 1992, 85:174-179.
3. Sess E.D., Carbonneau M.A., Meïté M., Peuchant E., Dumont M.F., Receveur M.C., et al. Marqueurs de la lipoperoxydation (Lpo), protéines inflammatoires et tocophérols plasmatiques dans les drépanocytoses homozygote et hétérozygote. Bull. Soc Path Ex 1998, 91:238-241.
4. Monnet P.D., Kane F., Konan-Waidhet D., Akpona S., Kora J., Diafouka F., et al. Evaluation of atherogenic risk in homozygous sickle cell disease: study of lipid and apolipoprotein AI and B plasma levels. Bull Soc Pathol Exot 1996, 89:278-281.
5. Kouamé-Koutouan A., Aboukoua-Kouassi N., Koffi D., Méité M., Sanogo I., Séry J.M. Nouvelle stratégie dans le diagnostic, la prévention et le suivi de l'ostéonécrose drépanocytaire en Côte d'Ivoire à partir de la scintigraphie osseuse. Médecine Nucléaire 2009, 33:604-608.
6. VanderJagt D.J., Shores J., Okorodudu A., Okolo S.N., Glew R.H. Hypocholesterolemia in Nigerian children with sickle cell disease. J Trop Pediatr 2002, 48:156-161.
7. Rahimi Z., Merat A., Haghshenass M., Madani H., Rezaei M., Nagel R.L. Plasma lipids in Iranians with sickle cell disease: hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clin Chim Acta 2006, 365:217-220.
8. Belcher J.D., Marker P.H., Geiger P., Girotti A.W., Steinberg M.H., Hebbel R.P., et al. Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. J Lab Clin Med 1999, 133:605-612.
9. Thompson P.D., Cullimane M., Sady S.P. Modest changes in high density lipoprotein concentration and metabolism with prolonged exercise training. Circulation 1988, 78:25-34.
10. Stone W.L., Payne P.H., Adebonojo F.O. Plasma-vitamin E and low plasma lipoprotein levels in sickle cell anemia patients. J Assoc Acad Minor Phys 1990, 1:12-16.
11. Monnet D., Edjeme N.E., Ndri K., Hauhouot-Attoungbre M.L., Ahibo H., Sangare A., et al. Lipoprotein (a) and acute phase inflammation proteins in homozygous sickle cell disease. Ann Biol Clin 2002, 60:101-103.
12. Saile R., Fruchart J.C. L'apolipoprotéine sérique amyloïde A (APO S AA). Implication dans l'inflammation et dans les modifications des lipoprotéines. Ann Biol Clin 1990, 48:77-85.
13. Erasmus R.T., Olukoga A.O., Ojuawo O. Plasma lipids and lipoproteins in Nigerian children with sickle cell anemia. Ann Trop Paediatr 1990, 10:421-423.
14. Zhang B., Bai H., Liu R., Kumagai K., Itabe H., Takano T., et al. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men. Metabolism 2004, 53:423-429.
15. Holvoet P., Jenny N.S., Schreiner P.J., Tracy R.P., Jacobs D.R. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 194:245-252.
16. El Hazmi M.A., Jabbar F.A., Warsy A.S. Cholesterol and triglycerids level in patients with sickle cell anemia. Scand J Clin Lab Invest 1987, 47:351-354.
17. Monnet D., Kané F., Konan-Waidhet D., Diafouka F., Sangaré A., Yapo A.E. Lipid, apolipoprotein AI and B levels in Ivorian patients with sickle cell anaemia. Ann Biol Clin 1996, 54:285-288.
18. Castelli W.P. Cholesterol and lipids in the risk of coronary artery disease. The Framingham Heart Study. Can J Cardiol 1988, 4:5-10.
19. Rouvillain Jl, Catonné Y., Uzel A.P., Delattre O., Pascal-Moussellard H. La nécrose drépanocytaire de la tête fémorale chez l'enfant et l'adolescent. À propos de 54 cas. Ann Orthop Ouest 2000, 32:147-155.